Gradient Pharmaceuticals, Inc. — Form D
Gradient Pharmaceuticals, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2016-10-24. The offering totals $1.5M, of which $850K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-10-24
- Form: D
- Accession: 0001688087-16-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $850K
- Remaining: $650K
- Investors: 1
- Date of first sale: 2016-10-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-273059
Issuer
- Name: Gradient Pharmaceuticals, Inc.
- CIK: 0001688087
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 2450 HOLCOMBE BLVD., HOUSTON, TX, 77021
- Phone: (713) 357-1024
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Valentin Angelkov | Director | Houston, TX |
| MAX DUCKWORTH | Director | MIDDLETON, WI |
| Martin Martinov | Director | Houston, TX |
| Valentin Angelkov | Executive Officer | Houston, TX |
| Martin Martinov | Executive Officer | Houston, TX |
More